GSGTF: GenSight Biologics S.A. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 58.53
Enterprise Value ($M) n/a
Book Value ($M) -26.92
Book Value / Share -0.21
Price / Book n/a
NCAV ($M) -32.33
NCAV / Share -0.25
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.93
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.24
Current Ratio 0.24

Balance Sheet (mrq) ($M)
Current Assets 5.34
Assets 10.76
Liabilities 37.68
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.62
Operating Income -15.81
Net Income -14.00

Cash Flow Statement (mra) ($M)
Cash From Operations -12.94
Cash from Investing 0.02
Cash from Financing 13.54

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
GPLB – Green Planet Bioengineering Co., Ltd. GRTX – Galera Therapeutics, Inc.
GSAC – GelStat Corp. GSTC – GlobeStar Therapeutics Corporation
HENC – Hero Technologies Inc.


Financial data and stock pages provided by
Fintel.io